ES2070126T3 - Derivados de piridazinamina. - Google Patents

Derivados de piridazinamina.

Info

Publication number
ES2070126T3
ES2070126T3 ES88202572T ES88202572T ES2070126T3 ES 2070126 T3 ES2070126 T3 ES 2070126T3 ES 88202572 T ES88202572 T ES 88202572T ES 88202572 T ES88202572 T ES 88202572T ES 2070126 T3 ES2070126 T3 ES 2070126T3
Authority
ES
Spain
Prior art keywords
rent
formula
compounds
piridazinamine
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88202572T
Other languages
English (en)
Inventor
Raymond A Stokbroekx
Der Aa Marcel J M Van
Marcel G M Luyckx
Gilbert A J Grauwels
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Original Assignee
Janssen Pharmaceutica NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NV filed Critical Janssen Pharmaceutica NV
Application granted granted Critical
Publication of ES2070126T3 publication Critical patent/ES2070126T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/20—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pyrrole Compounds (AREA)

Abstract

NUEVOS DERIVADOS DE PIRIDAZINAMINA DE FORMULA(I), EN LA QUE R1 ES H, ALQUILO DE 1 A 6 C, HALO, OH, SH, TRIFLUORMETIL, AMINO, MONO O DI (ALQUIL DE 1 A 6 C) - AMINO, CIANO ALQUILOXI DE 1 A 6 C, ARILOXI, ARILALQUILOXI DE 1 A 6 C, ALQUILTIO DE 1 A 6 C, ARILTIO, ALQUIL (DE 1 A 6 C) - SULFINIL O - SULFONILO, ARIL SULFINILO, ARIL - SULFONILO, ALQUIL (DE 12 A 6 C) - CARBONILO O OXICARBONILO, O ARILO; R2 Y R3 SON INDEPENDIENTEMENTE H, ALQUILO DE 1 A 6 C, O JUNTOS PUEDEN FORMAR UN RADICAL BIVALENTE DE FORMULA - CH = CH - XCH = CH -; G ES UN RADICAL BIVALENTE SELECCIONADO DE ENTRE LOS DE LAS FORMULA(II); Y X ES O, S, NR8 O UN ENLACE DIRECTO (SIENDO R8 H O ALQUILO DE 1 A 6 C). TAMBIEN SE INCLUYEN LAS SALES DE ADICION DE ACIDO FARMACEUTICAMENTE ACEPTABLES Y SUS POSIBLES ISOMEROS ESTEROQUIMICOS. LOS COMPUESTOS CITADOS SON ANTIVIRICOS. EN LA INVENCION SE INCLUYEN TAMBIEN COMPOSICIONES FARMACEUTICAS QUE CONTINEN DICHOS COMPUESTOS COMO INGREDIENTE ACTIVO Y METODOS PARA LA PREPARACION DE LOS COMPUESTOS YDE LAS COMPOSICIONES FARMACEUTICAS.
ES88202572T 1987-11-23 1988-11-17 Derivados de piridazinamina. Expired - Lifetime ES2070126T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12453087A 1987-11-23 1987-11-23

Publications (1)

Publication Number Publication Date
ES2070126T3 true ES2070126T3 (es) 1995-06-01

Family

ID=22415413

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88202572T Expired - Lifetime ES2070126T3 (es) 1987-11-23 1988-11-17 Derivados de piridazinamina.

Country Status (26)

Country Link
EP (1) EP0320032B1 (es)
JP (1) JPH0629255B2 (es)
KR (1) KR0125280B1 (es)
CN (1) CN1021328C (es)
AT (1) ATE117296T1 (es)
AU (1) AU611504B2 (es)
BG (1) BG60676B1 (es)
CA (1) CA1327573C (es)
DE (1) DE3852816T2 (es)
DK (1) DK651288A (es)
ES (1) ES2070126T3 (es)
FI (1) FI92584C (es)
GR (1) GR3015816T3 (es)
HU (1) HU200762B (es)
IE (1) IE65768B1 (es)
IL (1) IL88429A (es)
JO (1) JO1552B1 (es)
MA (1) MA21446A1 (es)
MY (1) MY104343A (es)
NO (1) NO171980C (es)
NZ (1) NZ226920A (es)
PH (1) PH26670A (es)
PT (1) PT89047B (es)
SU (1) SU1724013A3 (es)
TN (1) TNSN88128A1 (es)
ZA (1) ZA888744B (es)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5106973A (en) * 1987-11-23 1992-04-21 Janssen Pharmaceutica N.V. Pyridzainamine derivatives
US5070090A (en) * 1989-05-15 1991-12-03 Janssen Pharmaceutica N.V. Antipicorpaviral herterocyclic-substituted morpholinyl alkylphenol ethers
GB8911158D0 (en) * 1989-05-16 1989-07-05 Janssen Pharmaceutica Nv Antiviral pyridazinamines
JO1645B1 (en) * 1989-12-26 1991-11-27 شركة جانسين فارماسوتيكا ان. في Pyridazine compounds are antibacterial viruses
US5169855A (en) * 1990-03-28 1992-12-08 Du Pont Merck Pharmaceutical Company Piperidine ether derivatives as psychotropic drugs or plant fungicides
MX9100513A (es) * 1990-08-06 1992-04-01 Smith Kline French Lab Compuestos
FR2668151A1 (fr) * 1990-10-23 1992-04-24 Rhone Poulenc Agrochimie Composes a groupe triazolopyridazine leurs preparations et compositions herbicides les contenant.
HU214320B (hu) * 1991-12-20 1998-03-02 EGIS Gyógyszergyár Rt. Eljárás új 3(2H)-piridazinon-származékok és ezeket tartalmazó gyógyszerkészítmények előállítására
CA2099630A1 (en) * 1992-07-02 1994-01-03 Guy Dominic Diana Heterocyclyl-phenoxyalkyl-piperidinylpyridazines as antiviral agents
US5242924A (en) * 1992-07-02 1993-09-07 Sterling Winthrop Inc. Tetrazolyl-(phenoxy and phenoxyalkyl)-piperidinylpyridazines as antiviral agents
US5364865A (en) * 1992-12-30 1994-11-15 Sterling Winthrop Inc. Phenoxy- and phenoxyalkyl-piperidines as antiviral agents
EP0691959B1 (en) * 1993-03-29 1998-07-22 Zeneca Limited Heterocyclic derivatives as platelet aggregation inhibitors
EP0690847A1 (en) * 1993-03-29 1996-01-10 Zeneca Limited Heterocyclic compounds as platelet aggregation inhibitors
US5652242A (en) * 1993-03-29 1997-07-29 Zeneca Limited Heterocyclic derivatives
US5753659A (en) * 1993-03-29 1998-05-19 Zeneca Limited Heterocyclic compouds
US5750754A (en) * 1993-03-29 1998-05-12 Zeneca Limited Heterocyclic compounds
ATE491689T1 (de) * 1997-10-27 2011-01-15 Neurosearch As Heteroaryl diazacycloalkane als cholinergische ligande für nikotin-acetylcholin-rezeptoren
US6683100B2 (en) 1999-01-19 2004-01-27 Novartis Ag Organic compounds
PL339836A1 (en) 1998-02-19 2001-01-02 Eisai Co Ltd Phtalazine compounds and therapeutic agents suitable to treat erection disorders
US6194181B1 (en) 1998-02-19 2001-02-27 Novartis Ag Fermentative preparation process for and crystal forms of cytostatics
US6316500B1 (en) * 1999-01-05 2001-11-13 Isp Investments Inc. Aliphatically unsaturated hydroxy benzoates and preservative compositions thereof
AUPR213700A0 (en) 2000-12-18 2001-01-25 Biota Scientific Management Pty Ltd Antiviral agents
KR100955015B1 (ko) 2001-08-15 2010-04-28 이코스 코포레이션 2ｈ-프탈라진-1-온 및 이것의 사용 방법
US7390813B1 (en) 2001-12-21 2008-06-24 Xenon Pharmaceuticals Inc. Pyridylpiperazines and aminonicotinamides and their use as therapeutic agents
JP4544999B2 (ja) * 2002-11-25 2010-09-15 持田製薬株式会社 ４−ヒドロキシピペリジン誘導体を有効成分とする呼吸器疾患治療剤
EP1648874B1 (en) 2003-07-30 2011-10-05 Xenon Pharmaceuticals Inc. Piperazine derivatives and their use as therapeutic agents
US7759348B2 (en) 2003-07-30 2010-07-20 Xenon Pharmaceuticals Inc. Pyridazine derivatives and their use as therapeutic agents
US7754711B2 (en) * 2003-07-30 2010-07-13 Xenon Pharmaceuticals Inc. Pyridazine derivatives and their use as therapeutic agents
CN101712653A (zh) * 2003-07-30 2010-05-26 泽农医药公司 哒嗪衍生物和它们作为治疗剂的用途
SG154433A1 (en) * 2004-06-30 2009-08-28 Janssen Pharmaceutica Nv Phthalazine derivatives as parp inhibitors
AR051091A1 (es) 2004-09-20 2006-12-20 Xenon Pharmaceuticals Inc Derivados heterociclicos y su uso como inhibidores de la estearoil-coa desaturasa
CA2580857A1 (en) 2004-09-20 2006-09-28 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
US7829712B2 (en) 2004-09-20 2010-11-09 Xenon Pharmaceuticals Inc. Pyridazine derivatives for inhibiting human stearoyl-CoA-desaturase
EP2289510A1 (en) 2004-09-20 2011-03-02 Xenon Pharmaceuticals Inc. Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-coa desaturase enzymes
CA2580762A1 (en) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as therapeutic agents
AU2005286648A1 (en) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors
EP1807085B1 (en) 2004-09-20 2013-08-21 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
AU2006343359A1 (en) 2005-06-03 2007-11-15 Xenon Pharmaceuticals Inc. Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors
EP1910290A2 (en) * 2005-06-30 2008-04-16 Prosidion Limited Gpcr agonists
CN1887875B (zh) * 2005-06-30 2011-04-06 深圳市东阳光实业发展有限公司 哒嗪胺衍生物及其用于制备小rna病毒抑制剂的用途
RU2499795C2 (ru) 2005-07-04 2013-11-27 Хай Пойнт Фармасьютикалс, ЛЛС Антагонисты гистаминовых н3-рецепторов
SG163547A1 (en) 2006-05-29 2010-08-30 High Point Pharmaceuticals Llc 3- (1, 3-benz0di0x0l-5-yl) -6- (4-cyclopropylpiperazin-1-yl) -pyridazine, its salts and solvates and its use as histamine h3 receptor antagonist
EP2014656A3 (en) 2007-06-11 2011-08-24 High Point Pharmaceuticals, LLC New heteocyclic h3 antagonists
CN101864003B (zh) * 2010-06-11 2012-05-02 漆又毛 一种6-脱氧硫醚氨基酸环糊精衍生物的合成方法
CN102344416B (zh) * 2010-08-02 2015-09-16 中国人民解放军军事医学科学院毒物药物研究所 哒嗪衍生物及其作为抗小rna病毒感染药物的用途
CN102485717B (zh) * 2010-12-06 2015-12-02 中国人民解放军军事医学科学院毒物药物研究所 噻唑胺衍生物及其作为抗小rna病毒感染药物的用途
TW201329025A (zh) 2011-11-01 2013-07-16 Astex Therapeutics Ltd 醫藥化合物
EP3749697A4 (en) 2018-02-05 2021-11-03 Bio-Rad Laboratories, Inc. CHROMATOGRAPHY RESIN WITH LIGAND MIXED MODE ANIONIC / HYDROPHOBIC EXCHANGE
CN118047485B (zh) * 2024-04-08 2024-06-25 西安文理学院 一种污水治理的复合微生物菌剂及其制备方法和应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES8802151A1 (es) * 1985-07-31 1988-04-01 Janssen Pharmaceutica Nv Un procedimiento para la preparacion de nuevos piridazinaminas.

Also Published As

Publication number Publication date
IE883486L (en) 1989-05-23
CN1021328C (zh) 1993-06-23
IL88429A (en) 1993-05-13
MY104343A (en) 1994-03-31
SU1724013A3 (ru) 1992-03-30
CN1033274A (zh) 1989-06-07
DK651288D0 (da) 1988-11-22
GR3015816T3 (en) 1995-07-31
FI885409A7 (fi) 1989-05-24
NO885190L (no) 1989-05-24
JO1552B1 (en) 1989-12-16
DE3852816T2 (de) 1995-06-08
KR890008126A (ko) 1989-07-08
JPH01207278A (ja) 1989-08-21
KR0125280B1 (ko) 1997-12-05
CA1327573C (en) 1994-03-08
PT89047A (pt) 1988-12-01
ATE117296T1 (de) 1995-02-15
EP0320032A1 (en) 1989-06-14
NZ226920A (en) 1990-06-26
HUT48617A (en) 1989-06-28
PT89047B (pt) 1993-03-31
DE3852816D1 (de) 1995-03-02
IL88429A0 (en) 1989-06-30
FI92584C (fi) 1994-12-12
HU200762B (en) 1990-08-28
EP0320032B1 (en) 1995-01-18
AU2575188A (en) 1989-05-25
TNSN88128A1 (fr) 1990-07-10
ZA888744B (en) 1990-07-25
JPH0629255B2 (ja) 1994-04-20
FI92584B (fi) 1994-08-31
FI885409A0 (fi) 1988-11-22
NO171980C (no) 1993-05-26
PH26670A (en) 1992-09-15
BG86132A (bg) 1993-12-24
DK651288A (da) 1989-05-24
IE65768B1 (en) 1995-11-15
NO885190D0 (no) 1988-11-22
NO171980B (no) 1993-02-15
AU611504B2 (en) 1991-06-13
BG60676B1 (bg) 1995-12-29
MA21446A1 (fr) 1989-07-01

Similar Documents

Publication Publication Date Title
ES2070126T3 (es) Derivados de piridazinamina.
ES2094721T3 (es) Analogos de la camptotecina solubles en agua.
DE3567870D1 (en) Xanthine derivatives, processes for their preparation and pharmaceutical compositions containing them
ES556381A0 (es) Un procedimiento para la preparacion de nuevas (4-piperidinilmetil y heteropurinas)
ES2142798T3 (es) Derivados de 3-amido pirazol, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
ES2076935T3 (es) Compuesto de pirazolopiridina y procedimientos para su preparacion.
PT88577A (pt) Process for the manufacture of novel substituted n-(1-alkyl-3-hydroxy-4-piperidinyl)benzamides
PT91364A (pt) Processo para a preparacao de derivados de 3-piperazinil-benzazol e de composicoes farmaceuticas que os contem
ES2045083T3 (es) Un procedimiento para preparar un compuesto quimico.
ES2056073T3 (es) Aril-aralquil-eteres, procedimientos para su preparacion y composicion farmaceutica que los comprende.
ES8800164A1 (es) Un procedimiento para preparar derivados de imidazolidina
ES2153457T3 (es) Amino-alquil-benzoxazolinonas y benzotiazolinonas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen.
ES2130548T3 (es) Nuevos derivados alquil-amino-indanos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES2172023T3 (es) Nuevos derivados tetrahidro-piridinicos sustituidos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
JPS6466116A (en) Antiemetic containing specific substituted phenylalkylamino and amino acid derivatives and compound selected from other serotonin drying drugs
PT91613A (pt) Process for the preparation of antihypertensive 3-piperidinyl-indazole derivatives
ES2065192T3 (es) Nuevos nicotinatos de diacil-glicerol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES8304940A1 (es) &#34;procedimiento para la preparacion de heteroariloxipropanolaminas&#34;.
ES8506643A1 (es) Procedimiento para la preparacion de derivados d,l-, d-y l-del acido 3-imidazolil-2-amino-propionico
ES2178128T3 (es) Nuevos derivados de bis-(4,3-b)-carbazol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 320032

Country of ref document: ES